Search
News
DoubleVerify Q2 2026 earnings: Cost control lifts margins on 3% revenue growth
DoubleVerify’s Q2 2026 revenue rose 3% year over year to $193.8 million, while diluted GAAP EPS increased to $0.08 from $0.05. Adjusted EBITDA reached $65.3 million and margin expanded to 34% from 30% as operating expenses declined. Measurement revenue grew 6% and Supply-Side revenue rose 13%, offsetting a 1% decline in Activation. Quarterly free cash flow increased to $65.7 million, although first-half free cash flow remained below the prior-year period. DV also agreed to be acquired by Nielsen and withdrew its previous financial guidance while the transaction is pending.
TradingKey
Thu, Aug 6
Casella Waste Q2 2026 earnings: acquisitions lift revenue as margins narrow
Casella Waste Systems’ Q2 2026 revenue rose 16.9% to $543.7 million, supported by acquisitions, pricing and higher landfill volumes. Adjusted EBITDA increased 12.5% to $123.2 million, but the margin narrowed to 22.7% from 23.5% as elevated fuel costs created a 40-basis-point headwind despite recovery fees. GAAP net income fell 27.6% to $3.8 million. For 2026, Casella raised revenue guidance, lowered net income guidance, and reaffirmed its adjusted EBITDA and cash flow ranges, leaving acquisition integration, leverage and margin conversion as the main operating issues.
TradingKey
Thu, Aug 6
Arteris Q2 2026 earnings: Revenue rose 46% while losses widened
Arteris reported Q2 2026 revenue of $24.1 million, up 46% year over year, while its GAAP net loss widened to $14.1 million, or $0.30 per share. ACV plus royalties reached $99.5 million, up 44%, and RPO climbed 36% to $135 million, indicating stronger contracted activity. However, GAAP gross margin fell to 85% from 89% and operating expenses increased, pushing the operating loss to $13.9 million. Quarterly free cash flow improved to $8.6 million, while updated 2026 guidance calls for revenue of $95 million to $98 million.
TradingKey
Thu, Aug 6
INmune Bio Q2 2026 earnings: Tax rebate benefit narrows net loss
INmune Bio’s Q2 2026 earnings showed no revenue, a net loss of $1.3 million versus $24.5 million a year earlier, and diluted EPS of -$0.05 versus -$1.05. The narrower loss mainly reflected an Australian R&D tax rebate benefit and the absence of the prior-year $16.5 million impairment, rather than commercial sales. Cash was $18.4 million at June 30, while Ebstrocel advanced toward UK and U.S. filings and XPro received FDA Fast Track designation following Phase 2 biomarker findings in early Alzheimer’s disease.
TradingKey
Thu, Aug 6
Organogenesis Q2 2026 earnings: Wound care decline compresses margins
Organogenesis reported Q2 2026 net product revenue of $42.8 million, down 58% year over year, as Advanced Wound Care revenue fell 61%. Gross margin contracted to 45% from 73%, diluted loss per share widened to $0.77 from $0.10, and adjusted EBITDA loss reached $34.4 million. The company ended June with $46.8 million in cash, cash equivalents and restricted cash and revised full-year net revenue guidance to $179 million-$215 million as the expected market recovery proceeds more slowly.
TradingKey
Thu, Aug 6
Red Cat Q2 2026 Earnings: Revenue Jumps but Losses Widen
Red Cat (NASDAQ: RCAT) reported Q2 2026 revenue of $20.2 million, up 527% year over year, while diluted loss per share widened to $0.26 from $0.15. Gross margin improved to 16.1%, but operating expenses rose to $41.9 million and the net loss expanded to $35.3 million. Cash reached $325.6 million after substantial equity financing, even as first-half operating cash outflow was $78.7 million and inventory climbed to $84.8 million. The company reaffirmed its full-year revenue target of $150 million to $180 million.
TradingKey
Thu, Aug 6
Hamilton Q2 2026 Earnings: Catastrophe Losses Cut Underwriting Profit
Hamilton Insurance Group’s Q2 2026 total revenue rose approximately 13.3% year over year to $839.6 million, while net premiums earned increased 14.6% to $586.0 million. Diluted EPS fell to $1.42 from $1.79 as $49.9 million of catastrophe losses, led by the Middle East conflict, pushed the combined ratio to 95.0% from 86.8% and reduced underwriting income to $29.1 million. International premium growth outpaced Bermuda, while $141.3 million of highlighted net investment income helped support profitability despite weaker underwriting results.
TradingKey
Thu, Aug 6
ICU Medical Q2 2026 earnings: Organic revenue rises 6% as guidance increases
ICU Medical’s Q2 2026 revenue rose 1% to $551.7 million, while organic revenue increased 6% after excluding the IV Solutions divestiture and currency effects. GAAP diluted EPS fell to $0.76 from $1.43 because the prior-year quarter included a $41.8 million business-sale gain, but adjusted EPS rose to $2.37 and adjusted EBITDA reached $110.0 million. Gross margin reached 43%, Infusion Systems led product-line growth, free cash flow improved to $61.7 million, and the company raised its fiscal 2026 guidance across GAAP and adjusted earnings measures.
TradingKey
Thu, Aug 6
CytoSorbents Q2 2026 earnings: Margins improve despite flat revenue
CytoSorbents’ Q2 2026 revenue was $9.6 million, essentially unchanged year over year, while diluted EPS moved to a $0.07 loss from $0.03 of earnings. Gross margin rose to 73% from 71%, and the operating loss narrowed 27% to $2.6 million as manufacturing efficiency and tighter costs improved underlying economics. However, foreign-currency effects drove a $4.4 million GAAP net loss, and unrestricted cash ended June at $4.4 million. Germany remained the main commercial drag, while DrugSorb-ATR regulatory work and the cash-flow breakeven objective remain central watchpoints.
TradingKey
Thu, Aug 6
MSC Income Q2 2026 earnings: Fair value gains lift NAV as NII falls
MSC Income Fund’s Q2 2026 total investment income was $35.7 million, essentially flat year over year, while GAAP net investment income fell 26% to $12.0 million, or $0.26 per share. Adjusted NII was $0.33 per share. A $19.0 million net fair value increase, including an $11.6 million gain on the Centre Technologies exit, lifted net assets from operations to $29.3 million and NAV to $16.51 per share. Investors should monitor non-accrual exposure, funding costs, the October 2026 notes maturity, and dividend coverage.TradingKey
Thu, Aug 6
Akamai Q2 2026 Earnings: Cloud Growth Came With Margin Pressure
Akamai’s Q2 2026 revenue increased 5% year over year to $1.100 billion, led by 39% growth in Cloud Infrastructure Services and 10% growth in security. GAAP diluted EPS fell 27% to $0.52 as GAAP operating margin contracted to 7% from 15%; non-GAAP EPS declined 8% to $1.59. Operating cash flow was $326 million, while capex reached 32% of revenue on an accrual basis. The company issued Q3 and full-year 2026 guidance and highlighted more than $2.8 billion of year-to-date multi-year cloud infrastructure contracts.
TradingKey
Thu, Aug 6
Dentsply Sirona Q2 2026 Earnings: Sales Decline as GAAP Margins Recover
Dentsply Sirona’s Q2 2026 net sales fell 4.1% to $898 million, while GAAP diluted EPS improved to $0.18 from a $0.22 loss a year earlier. Operating cash flow rose to $99 million from $48 million, helped by about $44 million of tariff refunds and better inventory and payables management. However, constant-currency sales declined 6.3%, led by weakness in Orthodontic and Implant Solutions, while the company maintained its 2026 net sales and adjusted EPS guidance.
TradingKey
Thu, Aug 6
Progyny Q2 2026 Earnings: Margin Expansion Lifts Net Income
Progyny’s Q2 2026 revenue increased 5.3% to $350.5 million, while GAAP diluted EPS rose to $0.34 from $0.19 and gross margin expanded to 25.5% from 23.7%. Excluding $17.2 million of prior-year revenue from a large client that did not renew, revenue grew 11.0%. Fertility benefit revenue outpaced pharmacy growth, and lower stock-based compensation helped lift net income to $28.1 million. Operating cash flow was $50.4 million. Progyny guided to 2026 revenue of $1.360 billion to $1.385 billion and adjusted EBITDA of $233 million to $240 million.
TradingKey
Thu, Aug 6
Full House Resorts Q2 2026 earnings: Casino ramp-up lifts revenue and EBITDA
Full House Resorts’ Q2 2026 revenue increased 5.6% year over year to $78.1 million, while diluted loss per share narrowed to $0.24 from $0.29. Adjusted EBITDA rose 19.5% to $13.3 million as American Place set property records and Chamonix/Bronco Billy’s moved closer to break-even. GAAP operating income reached $2.3 million, versus a small loss a year earlier, but $10.8 million of net interest expense kept the company at an $8.7 million net loss. Key follow-up issues include refinancing, construction financing, and property ramp-up execution.
TradingKey
Thu, Aug 6
nLIGHT Q2 2026 earnings: Product revenue drives a record quarter
nLIGHT’s Q2 2026 revenue rose 33.8% to a record $82.6 million, led by 45% growth in Products revenue to $59.4 million. Gross margin improved 120 basis points to 31.1%, while GAAP net loss narrowed to $1.3 million, or $0.02 per diluted share. Adjusted EBITDA reached $10.7 million. Q3 guidance calls for $63 million to $73 million in revenue after supply-chain constraints shifted about $17 million of expected product shipments into future quarters. Aerospace and Defense revenue grew approximately 41% and remained the largest end market.
TradingKey
Thu, Aug 6
Karman Q2 FY2026 Earnings: Revenue Rises 58% as Backlog Reaches $1.3 Billion
Karman Space & Defense’s fiscal Q2 2026 revenue rose 58.2% to $182.1 million, while diluted EPS increased to $0.11 from $0.05 and net income reached $14.0 million. Organic growth was 24.4%, quarterly bookings approached $500 million, and backlog climbed to $1.3 billion. GAAP margins improved, but adjusted EBITDA margin slipped to 30.0% from 30.7%. Karman also raised fiscal 2026 guidance to $730 million-$745 million in revenue and $215.0 million-$222.5 million in adjusted EBITDA.
TradingKey
Thu, Aug 6
BARK Fiscal Q1 2027 Earnings: DTC Contraction Persists Despite Lower Costs
BARK’s fiscal Q1 2027 revenue fell 23.4% to $78.8 million as DTC sales contracted, while diluted EPS improved to $0.08 from a $0.83 loss. GAAP gross margin rose to 72.7%, but a one-time fiscal 2026 tariff refund inflated margin and net income; normalized gross margin was 63.4%. Adjusted EBITDA reached $0.6 million, operating cash outflow narrowed to $3.5 million, and BARK reiterated full-year revenue guidance of $325 million to $340 million with $7 million to $10 million of adjusted EBITDA.
TradingKey
Thu, Aug 6
DraftKings Q2 2026 earnings: Sports monetization pressure leads to a GAAP loss
DraftKings' Q2 2026 revenue fell 4.6% to $1.443 billion, while diluted EPS shifted to a $0.14 loss from a $0.30 profit a year earlier. Adjusted EBITDA declined to $114.6 million from $300.6 million. Sports Consumer Volume rose 14.5%, but customer-friendly outcomes and promotional reinvestment pushed Sports Net Revenue Margin down to 6.8% and Sports Revenue down 10.6%. iGaming revenue grew 7.5%, and DraftKings maintained its FY2026 revenue and Adjusted EBITDA guidance despite the quarter's weaker profitability.
TradingKey
Thu, Aug 6
Grove Q2 FY2026 earnings: Cost cuts narrow losses despite a 16.9% revenue decline
Grove Collaborative’s fiscal Q2 2026 net revenue fell 16.9% year over year to $36.6 million as a smaller active-customer base and fewer DTC orders outweighed higher revenue per order. GAAP diluted EPS improved to -$0.03 from -$0.10, while adjusted EBITDA turned positive at $0.5 million as operating expenses declined 27.0%. Operating cash flow reached $1.3 million. Grove reaffirmed full-year revenue guidance of $142.5 million to $152.5 million and adjusted EBITDA guidance of breakeven to positive low-single-digit millions.
TradingKey
Thu, Aug 6
Cloudflare Q2 2026 Earnings: Revenue Rises 36% as Restructuring Widens GAAP Loss
Cloudflare’s Q2 fiscal 2026 revenue increased 36% year over year to $696.1 million, while non-GAAP diluted EPS rose to $0.29 from $0.21. GAAP operating loss widened to $205.7 million, largely reflecting a $150.7 million restructuring charge, and GAAP gross margin fell 3.1 percentage points to 71.8%. Free cash flow improved to $56.4 million, or 8% of revenue. The company issued Q3 revenue guidance of $736 million to $737 million as current remaining performance obligations grew 35%, leaving investors to weigh healthy demand against margin pressure.
TradingKey
Thu, Aug 6
Featured Tools
Top News
The Week Ahead: Fed Minutes, Walmart, Target and Home Depot Earnings to Test US Consumer Resilience
Oracle Stock Forecast: $630 Billion AI Order Backlog Awaits Revaluation, Can the Stock Continue to Recover?
New CEO Ternus Launches iPhone 18 Pro on September 9 — Can Apple Reverse Q3 China Miss Before Jackson Hole?
SK Hynix Stock Forecast: Can HBM4 Demand Drive a Breakout Toward $194?
Broadcom Stock Price Forecast: Can It Break $500 Before Earnings Amid Strong Custom AI Chip Demand?
